Lipigon Pharmaceuticals AB (publ)

OM:LPGO Stock Report

Market Cap: SEK 24.4m

Lipigon Pharmaceuticals Future Growth

Future criteria checks 5/6

Lipigon Pharmaceuticals is forecast to grow earnings and revenue by 139.5% and 127.6% per annum respectively.

Key information

139.5%

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth45.7%
Revenue growth rate127.6%
Future return on equityn/a
Analyst coverage

Low

Last updated21 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

OM:LPGO - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202615899N/A991
12/31/202522-5N/A-51
12/31/20249-22N/A-221
9/30/20249-22-33-32N/A
6/30/20249-20-16-16N/A
3/31/202416-13-18-18N/A
12/31/202316-12-14-14N/A
9/30/202316-14-14-14N/A
6/30/202316-16-28-28N/A
3/31/2023N/A-36-31-31N/A
12/31/2022N/A-38-37-37N/A
9/30/20220-43-43-43N/A
6/30/20221-48-47-47N/A
3/31/20221-45-42-42N/A
12/31/20212-41-35-35N/A
9/30/20213-31-30-30N/A
6/30/20214-21-19-18N/A
3/31/20214-12-14-14N/A
12/31/20204-8-9-9N/A
12/31/20192-5-6-6N/A
12/31/20180-4N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: LPGO is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.2%).

Earnings vs Market: LPGO is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: LPGO is expected to become profitable in the next 3 years.

Revenue vs Market: LPGO's revenue (127.6% per year) is forecast to grow faster than the Swedish market (-0% per year).

High Growth Revenue: LPGO's revenue (127.6% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if LPGO's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y